Trimedoxime bromide
Jump to navigation
Jump to search
Clinical data | |
---|---|
Routes of administration | Intramuscular injection |
ATC code |
|
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Elimination half-life | 2 hours (mean) |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ECHA InfoCard | 100.000.276 |
Chemical and physical data | |
Formula | C15H18Br2N4O2 |
Molar mass | 446.143 g·mol−1 |
Trimedoxime bromide (INN), also known as dipyroxime or TMB-4, is an oxime used in the treatment of organophosphate poisoning[1] It is chemically related to asoxime, pralidoxime, and obidoxime.[2]
References
- ^ Dhuguru J, Zviagin E, Skouta R (January 2022). "FDA-Approved Oximes and Their Significance in Medicinal Chemistry". Pharmaceuticals. 15 (1). Basel, Switzerland: 66. doi:10.3390/ph15010066. PMC 8779982. PMID 35056123.
- ^ Gupta R, Parmar M (2022). "Pralidoxime". StatPearls. Treasure Island (FL): StatPearls Publishing. PMID 32644334.
Categories:
- Articles with short description
- Short description matches Wikidata
- Drugs not assigned an ATC code
- Drugs with non-standard legal status
- ECHA InfoCard ID from Wikidata
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles containing unverified chemical infoboxes
- Cholinesterase reactivators
- Chemical substances for emergency medicine
- Aldoximes
- Pyridinium compounds
- All stub articles
- Medicinal chemistry stubs